Eisenstadt, September 11, 2024
Haemo Pharma and Zimmer MedizinSysteme announce their partnership
Haemo Pharma, a leading company in the field of regenerative medicine, announces its partnership with Zimmer MedizinSysteme known.
Through this cooperation, Haemo Pharma is expanding its portfolio with innovative product lines, such as cold air therapy devices Cryo6 and Cryo7, the high-energy induction therapy EmfieldPro, the high-energy laser therapy device OptonPro, as well as the radial shockwave devices ENPuls2.0, EnpulsPro and the focused shockwave system EnShock.
“We are pleased to add Zimmer MedizinSysteme's proven technologies to our portfolio, give our customers expanded access to advanced treatments and, together with our new partner, help shape the therapies of the future. “, Mag. Markus Mateyka explains managing director of Haemo Pharma.
An overview of the products:
Cryo6 and Cryo7: Innovative cold therapy systems for the treatment of pain and inflammation.
EmFieldPro: A powerful magnetic field therapy device that is used for targeted rehabilitation, improved blood circulation and pain relief.
OptonPro: High-precision laser technology to promote wound healing and cell regeneration.
ENpuls 2.0, ENpulsPro, EnShock.: Efficient radial and focused shockwave therapy devices to treat musculoskeletal problems and improve tissue repair.
More posts
Stem cell therapy for degenerative joint diseases
Lotteries Sporthilfe Gala 2024: A Celebration of Austrian Sports Talent
